Data / Research funding / Maryland / Friends Research Institute, Inc.
Friends Research Institute, Inc.: 21 NIH awards ($38.1M), fiscal years 2021 to 2026
Friends Research Institute, Inc. in Baltimore, MD is funded under 21 NIH awards ($38.1M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- YM5EKEVEGB75
- State
- Maryland
Awards
21 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment | NIH | National Institute on Drug Abuse | 2021 to 2023 | $7,640,612 | May 1, 2023 | April 30, 2026 | GORDON, MICHAEL SCOTT | reporter.nih.gov |
| Optimizing PrEP Implementation and Cost-effectiveness among Individuals with a Substance Use Disorder | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,316,145 | September 1, 2022 | September 17, 2025 | REBACK, CATHY J | reporter.nih.gov |
| A comparative effectiveness trial of sublingual versus extended-release buprenorphine with individuals leaving a carceral setting | NIH | National Institute on Drug Abuse | 2023 to 2025 | $3,097,234 | September 30, 2023 | June 30, 2029 | GORDON, MICHAEL SCOTT | reporter.nih.gov |
| Treating Polysubstance Use in Methadone Maintenance: Application of Novel Digital Technology | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,027,776 | September 30, 2022 | July 31, 2027 | ALEXANDER, KAREN | reporter.nih.gov |
| Identifying Suspected Drug Overdose Deaths in Near Real-Time Using Data Collected by Death Investigators | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,935,212 | September 30, 2022 | July 31, 2028 | HOCHSTATTER, KARLI RAE | reporter.nih.gov |
| Take-home expansion: Scope and impact study (THESIS) | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,483,369 | September 30, 2022 | June 30, 2027 | GRYCZYNSKI, JAN | reporter.nih.gov |
| Comparative- and cost-effectiveness research determining the optimal intervention for advancing individuals living with HIV to full viral suppression | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,451,049 | August 15, 2023 | September 17, 2025 | REBACK, CATHY J | reporter.nih.gov |
| Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B) | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,939,313 | April 15, 2019 | January 31, 2026 | GRYCZYNSKI, JAN | reporter.nih.gov |
| A patient preference trial of sublingual versus extended-release buprenorphine telemedicine and pharmacy linkage for individuals re-entering the community from jail | NIH | National Institute on Drug Abuse | 2025 | $1,393,922 | September 15, 2025 | May 31, 2030 | BLUE, THOMAS | reporter.nih.gov |
| Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial | NIH | National Institute on Drug Abuse | 2021 | $1,339,547 | September 30, 2018 | July 31, 2023 | SCHWARTZ, ROBERT P | reporter.nih.gov |
| Buprenorphine for probationers and parolees: Bridging the gap into treatment | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,190,062 | July 15, 2018 | April 30, 2026 | GORDON, MICHAEL SCOTT | reporter.nih.gov |
| Implementing a patient navigation intervention across a health system to improve outcomes for patients with opioid use disorder | NIH | National Institute on Drug Abuse | 2025 | $1,130,715 | September 30, 2023 | August 31, 2029 | ALEXANDER, KAREN | reporter.nih.gov |
| Continuing Care App for Justice-Involved Individuals with Substance Use Disorders | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,128,686 | June 1, 2023 | November 30, 2025 | GORDON, MICHAEL SCOTT | reporter.nih.gov |
| Getting Off: A Theory-based mHealth Intervention for Methamphetamine-using MSM | NIH | National Institute on Drug Abuse | 2021 to 2022 | $953,199 | July 15, 2018 | April 30, 2024 | REBACK, CATHY J | reporter.nih.gov |
| Implementing a patient navigation intervention across a health system to address treatment entry inequities | NIH | National Institute on Drug Abuse | 2023 | $946,763 | September 30, 2023 | August 31, 2025 | ALEXANDER, KAREN | reporter.nih.gov |
| A Patient Navigation Trial for Housing and Health (PATHH): A randomized controlled trial | NIH | National Institute of Nursing Research | 2025 | $783,321 | September 26, 2025 | July 31, 2030 | ALEXANDER, KAREN | reporter.nih.gov |
| Intervention to Reduce Internalized Stigma (IRIS) among People Living with HIV who use Substances | NIH | National Institute on Drug Abuse | 2022 to 2024 | $724,401 | September 1, 2022 | July 31, 2026 | FLETCHER, JESSE BRADFORD | reporter.nih.gov |
| Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment | NIH | National Institute on Drug Abuse | 2021 | $519,501 | August 15, 2016 | April 30, 2025 | GORDON, MICHAEL SCOTT | reporter.nih.gov |
| Addressing racial disparities in opioid overdose deaths using an open source peer recovery coach training and multimodal mobile health platform | NIH | National Institute on Drug Abuse | 2024 to 2025 | $506,459 | July 1, 2024 | April 28, 2026 | TOFIGHI, BABAK | reporter.nih.gov |
| Development and Testing of an Identity Measure for Transgender and Gender Diverse Persons | NIH | National Institute of Mental Health | 2022 to 2023 | $372,467 | September 15, 2022 | September 14, 2025 | FLETCHER, JESSE BRADFORD | reporter.nih.gov |
| Leveraging a time-limited opportunity to study the impact of an intervention for individuals bereaved by drug overdose | NIH | National Institute on Drug Abuse | 2025 | $197,250 | February 1, 2025 | January 31, 2027 | HOCHSTATTER, KARLI RAE | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 11 | $8,818,533 | 0 | $0 |
| 2024 | 9 | $5,312,370 | 0 | $0 |
| 2023 | 11 | $8,708,120 | 0 | $0 |
| 2022 | 9 | $9,766,742 | 0 | $0 |
| 2021 | 5 | $5,471,238 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Clinical Research
- Drug Abuse (NIDA only)
- Substance Misuse
- Behavioral and Social Science
- Clinical Trials and Supportive Activities
- Opioid Misuse and Addiction
- Opioids
- Health Services
- Social Determinants of Health
- Comparative Effectiveness Research
- Health Disparities Research
- Health Disparities and Racial or Ethnic Minority Health Research
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.